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The roles that astrocytes play in the evolution of abnormal network excitability in chronic neurological disor-
ders involving brain injury, such as acquired epilepsy, are receiving renewed attention due to improved
understanding of the molecular events underpinning the physiological functions of astrocytes. In epileptic
tissue, evidence is pointing to enhanced chemical signaling and disrupted linkage between water and potas-
sium balance by reactive astrocytes, which together conspire to enhance local synchrony in hippocampal
microcircuits. Reactive astrocytes in epileptic tissue both promote and oppose seizure development through
a variety of specific mechanisms; the new findings suggest several novel astrocyte-related targets for drug
development.Introduction
The first thing you have to consider is that these are not your
father’s astrocytes, those flaccid cells that lay at the bottom of
the dish, unable even to generate a spike. Today, astrocytes
are recognized as more than simple bit players on the brain’s
stage. For example, in the healthy brain, thrombospondins and
other proteins secreted by immature astrocytes control synapto-
genesis (Christopherson et al., 2005), and individual astrocytes
cradle and shepherd newborn dentate granule cells to their final
destinations (Shapiro et al., 2005).
Whether astrocytes play a role in information processing nor-
mally or in certain pathological conditions such as epilepsy is an
intriguing notion receiving increased attention. Epilepsy—a fam-
ily of neurological disorders characterized by the unpredictable
but recurrent occurrence of seizures—is one of the most com-
mon disorders of the brain. Approximately 3% of us who live to
the age of 80 will have developed epilepsy. Epileptic seizures
are uncontrolled sudden attacks of a convulsive or nonconvul-
sive nature associated with unusually intense neuronal firing.
Neuronal firing patterns during a seizure typically include periods
of asynchronous activity and periods of synchronous bursts. A
spatially restricted seizure focus in the brain can often be identi-
fied for epilepsies acquired after head trauma, tumors, or other
severe focal insults to the brain. Other epilepsies by contrast typ-
ically involve seizures that spread throughout the brain so rapidly
that the focus cannot be localized. The epileptic brain exists in
two functional states: the ictal state during a seizure and the lon-
ger interictal state between seizures. The interictal, or ‘‘epilepti-
form,’’ burst consists of a brief (50–200 ms) neuronal discharge
that is synchronous over several millimeters of tissue. Develop-
ment of an epileptic seizure requires physiological changes
that lead to both heightened neuronal excitability and abnormal
synchronization of discharge within the affected neuronal net-
work. The evident part that astrocytes play in this neurocentric
disorder is the subject of growing interest.
The functions of astrocytes in the healthy adult brain are tradi-
tionally considered to involve potassiumbuffering, interstitial vol-
ume control, andmaintenance of a low interstitial glutamate con-
centration. Astrocytic processes present sheet-like extensions
that enwrap neurons and blood vessels in the brain. Accumulat-168 Neuron 58, April 24, 2008 ª2008 Elsevier Inc.ing evidence points to functional heterogeneity within the astro-
cyte population of the healthy adult brain (Ridet et al., 1997;
Walz, 2000; Seifert et al., 2006). Reactive gliosis, a component
of neuroinflammation that involves structural and metabolic
changes in astrocytes andmicroglia, is often a prominent feature
ofmesial temporal lobe human epilepsy andmost animal models
of recurrent seizures. Threemajor questions related to the poten-
tial roles of reactive astrocytes in either seizure generation or
epileptogenesis are receiving much attention: Has astrocyte-
neuron glutamate signaling gone awry? Is water or potassium
balance impaired? And, does reactive gliosis cause, exacerbate,
or combat seizures? We will consider these issues and the evi-
dence for each in turn. A better understanding of the pro- and an-
ticonvulsant actions of reactive astrocytes could lead to novel
strategies for epilepsy. Several recent reviews complement the
discussion that follows (Amiry-Moghaddam and Ottersen,
2003; Kofuji and Newman, 2004; Volterra and Meldolesi, 2005;
Seifert et al., 2006; Halassa et al., 2007).
Excessive Astrocyte-Neuron Chemical Signaling
One of the most captivating changes in our view of astrocyte
functions is the gradual acceptance of the notion that astrocytes
can respond to neurotransmitters, hormones, and other stimuli
via increases in intracellular Ca2+, which in turn can promote
release of chemical mediators, including D-serine, ATP, and glu-
tamate (reviewed in Haydon and Carmignoto, 2006). The major
issues driving this field today are (1) exploring the cellular path-
ways that regulate this stimulus-release process, (2) identifying
the conditions under which it occurs, and (3) determining
whether and when such ‘‘gliotransmission’’ influences the excit-
ability of nearby neurons. A most intriguing question is whether
exuberant neuron-astrocyte-neuron transmitter-mediated sig-
naling promotes abnormal neuronal synchronization in epilepsy.
Glutamate Release from Astrocytes
Glutamate release from pure astrocyte cultures was demon-
strated by HPLC or enzymatic assays following treatment with
agonists of Gq-coupled GPCRs (Parpura et al., 1994; Jeftinija
et al., 1997; Bezzi et al., 1998). When glutamate is released
from astrocytes, what is the route? Several routes appear to
operate, including reverse transport (Rossi et al., 2000),
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volume-sensitive anion channels (Mongin and Kimelberg,
2005; Abdullaev et al., 2006; Liu et al., 2006; Ramos-Mandujano
et al., 2007), gap junction hemichannels (Ye et al., 2003), and
vesicular exocytosis (Jeftinija et al., 1997; Bezzi et al., 2004;
Bowser and Khakh, 2007; Xu et al., 2007). For example, Ra-
mos-Mandujano et al. (2007) showed that hypo-osmoticmedium
caused glutamate release from astrocytes in culture, a process
that was prevented by several volume-sensitive anion channel
blockers. They concluded that cell swelling such as occurs dur-
ing ischemia or seizures can cause astrocytic glutamate release.
Of the various routes for astrocytic glutamate release, perhaps
themost complete evidence is for Ca2+-dependent exocytosis of
vesicular glutamate from astrocytes. The evidence consists of
three parts. First, astrocytes, like many other non-neuronal cells
(Rothman, 2002; Bonifacino and Glick, 2004), express proteins
that mediate fusion of vesicles with cellular membranes (Bezzi
et al., 2004; Montana et al., 2006). These include the SNARE pro-
teins cellubrevin and synaptobrevin 2, the vesicular glutamate
transporters VGLUT1/2, and synaptotagmin IV, homologs of
which are required for Ca2+-mediated vesicle fusion in neurons.
These vesicle release proteins are, however, typically expressed
at much lower levels than their homologs in neurons. Second,
glutamate release from cultured astrocytes in response to me-
chanical stimulation could be prevented by omission of Ca2+ in
the medium or by selective proteolysis of SNARE proteins by
intracellular infusion of botulinum toxin (Araque et al., 2000).
Finally, burst-like release from DHPG-treated astrocytes of acri-
dine orange that had been concentratedwithin VGLUT-EGFP-la-
beled vesicles was revealed by the appearance of fluorescent
flashes, consistent with exocytotic release of vesicle contents
(Bezzi et al., 2004).
Modulation of Neuronal Excitability via Astrocytic
Release of Glutamate
Numerous studies have appeared reporting that astrocytic Ca2+
waves induce local glutamate release that acts on nearby neu-
rons to produce depolarization or neuronal Ca2+ transients (Pasti
et al., 1997; Parri et al., 2001; Angulo et al., 2004; Fellin et al.,
2004; Fiacco and McCarthy, 2004). The experimental design
has been progressively improved to rule out neuronal sources
of glutamate, and two recent studies now provide compelling
evidence that astrocytic glutamate release can influence the
strength of synaptic transmission at nearby synapses. Jourdain
et al. (2007) showed that strong repetitive depolarization of an
astrocyte by current pulses through a patch pipette increases
the frequency of spontaneous AMPA receptor-mediated minia-
ture EPSCs (mEPSC) recorded in nearby dentate granule cells.
Importantly, this effect was not seen following pulses delivered
extracellularly to the neuropil andwas insensitive to tetrodotoxin,
but was prevented by direct astrocytic infusion of the active light
chain of the tetanus toxin protease (TeNTLC), which had been
shown previously to prevent exocytosis by destroying a compo-
nent of the SNARE complex, and by NMDA receptor blockade.
These and other supporting results suggest that Ca2+-evoked
glutamate release from a strongly depolarized astrocyte acts
on presynaptic NMDA receptors to increase the probability
of transmitter release. They went on to show a role for the Gq-
coupled P2Y1 receptor, which is robustly expressed by dentateastrocytes. Their key experiment was to demonstrate that intro-
duction of the Ca2+ chelator BAPTA into astrocyte cytoplasm
was sufficient to abolish the P2Y1 receptor-mediated increase
in mEPSC frequency in nearby neurons. Repetitive stimulation
of the perforant path elicited Ca2+ signals in molecular layer as-
trocytes that could be reduced in amplitude by antagonists of
both metabotropic glutamate or P2Y1 receptors. Altogether,
this study builds a strong case for dentate gyrus astrocytes re-
sponding to intense perforant path activation by releasing a sub-
stance that activates NMDA receptors on presynaptic perforant
path terminals, which in turn potentiates synaptic transmission
by increasing the probability of transmitter release (Figure 1).
The second study by Perea and Araque (2007) showed that an
astrocytic Ca2+ transient induced by photostimulation of astro-
cytes loaded with caged Ca2+ was associated with increased
EPSC amplitude in nearby CA1 pyramidal cell synapses, which
was in turn caused by increased probability of transmitter release
rather than a postsynaptic modulation. Important controls con-
firmed that light flashes did not modify synaptic transmission if
(1) the pipette used to deliver the caged Ca2+ was placed in the
neuropil rather than an astrocyte, (2) the cage was omitted, or (3)
thedeliverypipette alsocontained the light chainofTeNT. Interest-
ingly, although the astrocytic Ca2+ surge was virtually immediate
after photostimulation, synaptic efficacy rosegradually over about
10min.The interveningstepswithin the latentperiodareunknown.
In both studies discussed above, intense astrocytic Ca2+ ele-
vations were followed by increased local presynaptic transmitter
release, but only in about one-third of tested synapses. Fiacco
et al. (2007) took a different approach to restrict Ca2+ transients
to astrocytes. They created a transgenic mouse that expresses
a foreign (non-brain) Gq-coupled receptor (MrgA1) selectively
in astrocytes. Activation of the MrgA1 receptor by the FLRFa
peptide elicited robust Ca2+ signals in most (80%–90%) astro-
cytes in hippocampal slices, but these Ca2+ transients restricted
Figure 1. Integrated Control of Synaptic Release Probability by
Astrocytes in Dentate Molecular Layer
Immunoelectron microscopy suggests the existence of NR2B-containing
NMDA receptors on perforant path terminals opposing astrocytic membranes
that contain vesicles close to the astrocytic plasmamembrane (Jourdain et al.,
2007). Cell-derived ATP and glutamate act on two astrocytic Gq-coupled
GPCRs, mGluR5 and P2Y1R, to increase [Ca2+]i and promote astrocytic
release of glutamate into the extrasynaptic space. The resulting activation of
presynaptic NMDA receptors appears to contribute to frequency facilitation
at perforant path synapses.Neuron 58, April 24, 2008 ª2008 Elsevier Inc. 169
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mEPSC amplitude or frequency in nearby CA1 pyramidal cells
(13 neurons from 13 slices were studied). Although no effects
were observed on spontaneous synaptic currents, to under-
stand the potential role of astrocytic Ca2+ signaling in epilepsy,
it will be important to explore synaptic plasticity in MgrA1 mice.
Fiacco et al. (2007) concluded from this study that Ca2+ eleva-
tion, per se, is not a sufficient stimulus for astrocytic glutamate
release.
Given these disparate findings, one wonders whether an un-
identified variable determines whether an astrocytic Ca2+ tran-
sient will influence local synaptic transmission. For example,
Ca2+ elevationmight act in concert with other signaling pathways
(e.g., MAPK pathways) to trigger glutamate release but might not
be sufficient by itself. Whereas P2Y1 and mGluR5 receptors are
known to engagemultiple signaling pathways (Peavy et al., 2002;
Fam et al., 2003; Neary et al., 2003; Edling et al., 2007), to date,
MrgA1 is only known to signal via Gq/11 (Han et al., 2002). In
sum, it is clear that Ca2+-dependent glutamate release from
astrocytes can, under certain conditions, influence the strength
of nearby excitatory synapses in the hippocampus. This exciting
development begs the next question.
Does Astrocytic Glutamate Release Synchronize
Neuronal Activity?
Astrocytic glutamate release can thus enhance nearby excit-
atory synaptic transmission, but the specific role of this process
in epilepsy has not been defined. It was recently proposed that
slow inward currents (SICs) recorded in hippocampal neurons
are caused by astrocytic glutamate release (Angulo et al.,
2004; Fellin et al., 2004; Tian et al., 2005) and, moreover, that
SICs represent the ‘‘paroxysmal depolarizing shift’’ (PDS) under-
lying an interictal burst (Tian et al., 2005). Indeed, many of the
in vitro hippocampal models of synchronous epileptiform burst-
ing or electrographic seizures that have been studied for de-
cades are associated with the appearance of SICs in hippocam-
pal pyramidal neurons (Tian et al., 2005). Although the SIC itself
has a similar time course as the PDS, it almost certainly reflects
an entirely distinct event. That is, the hallmarks of SICs are (1)
resistance to TTX, (2) sensitivity to blockade of NMDA receptors,
and (3) synchrony over short distances (<100 mm). By contrast,
PDS differ from SICs in being (1) blocked by TTX, (2) truncated
but not eliminated by NMDA receptor blockers, and (3) synchro-
nous over many millimeters of brain tissue (Korn et al., 1987;
Fellin et al., 2006). With respect to the sensitivity to NMDA recep-
tor blockers in particular, PDS, interictal-like burst firing, and
more prolonged seizure-like events can be produced by a large
number of conditions, which are variably sensitive to NMDAR
blockers. For example, D-APV truncates but does not suppress
PDS caused by GABAA receptor blockade (Dingledine et al.,
1986), whereas PDS in low Ca2+ are insensitive to D-APV (Heine-
mann et al., 1985). Taken together, these findings support the
conclusion that the PDS and SIC are distinct events.
Although astrocyte-induced SICs in nearby pyramidal neurons
are not epileptiform bursts per se, they represent a very interest-
ing, newly recognized synchronizing mechanism that appears to
be particularly prominent in juveniles. Using paired field poten-
tials or cellular Ca2+ recordings, three groups (Angulo et al.,
2004; Fellin et al., 2004; Tian et al., 2005) showed that SICs are170 Neuron 58, April 24, 2008 ª2008 Elsevier Inc.synchronous only over short distances of 100 mm. This is
a key finding and recalls the observation that individual astro-
cytes have spatial exclusivity over60mm,withinwhich other as-
trocytes are virtually excluded (Bushong et al., 2002). The sphere
of influence of amodest cluster of two to three astrocytes is even
smaller than that of microcircuits (Grillner et al., 2005) but seems
well suited to mediate highly local neuron synchrony. Ca2+ un-
caging in a single astrocyte can be followed by SICs in nearby
neurons with a latency as low as 400 ms (Tian et al., 2005), al-
though more characteristically the latency is several seconds.
Given their long and variable latency, SICs seem better suited
to elevating the general excitability of a local neuron population
rather thanbeinga component ofwidespread synchronous firing.
SICs were proposed to be caused by astrocytic release of glu-
tamate (Angulo et al., 2004; Fellin et al., 2004; Tian et al., 2005).
Albeit a remote possibility, neuronal alternatives to an astrocytic
source of glutamate, such as release of glutamate from nonsy-
naptic (dendrites or soma) sites (cf. Zaidi and Matthews, 1999)
or release from injured neurons, have not been entirely ruled
out experimentally. Hippocampal slices often require some
type of conditioning before SICs appear, for example multiple
stimulus trains (Fellin et al., 2004), multiple puffs of glutamate
(Xu et al., 2007), or prolonged exposure to DHPG or altered ionic
conditions. Such conditioning treatments invariably induce as-
trocyte swelling, and the possibility that swelling or the conse-
quent shrinkage in extracellular space is a prerequisite for SICs
must be considered. Hippocampal slices are typically incubated
in a holding chamber for approximately an hour before use. This
might be long enough to initiate reactive gliosis in response to in-
jury during the cutting process. Astrocyte swelling elicits a ho-
meostatic volume-control mechanism that involves the release
of glutamate, chloride, and other anions through volume-sensi-
tive organic anion channels (Anderson and Swanson, 2000).
This process might contribute to the variability in observation
of SICs in different laboratories (cf. Fiacco et al., 2007). Indeed,
Fiacco et al. (2007) reported that hypo-osmotic medium reliably
elicited SICs, even in mice that lacked the IP3R2 receptor, which
is required for intracellular Ca2+ release in astrocytes. Bafilomy-
cin, which blocks vesicular transmitter release in neurons, did
not prevent SICs in the IP3R2 knockout mice. Collectively, these
results demonstrate that SICs can be produced in pathologic
conditions involving cell swelling and do not necessarily require
vesicular neurotransmitter release from neurons or IP3 receptor-
dependent Ca2+ elevation in astrocytes.
In slices bathed in Mg-free, picrotoxin-containing ACSF, SICs
were observedmany seconds after an LTP-like stimulus train de-
livered to the Schaffer collateral input or after perfusion of hippo-
campal slices with the group I mGluR agonist DHPG (Angulo
et al., 2004; Fellin et al., 2004). DHPG-evoked SICswere reduced
in amplitude by the NR2B-selective NMDA receptor antagonist
ifenprodil and were resistant to tetrodotoxin and to a tetanus
toxin fragment that blocks excitatory synaptic transmission. A
similar phenomenon, which is TTX resistant and variably blocked
by NMDA receptor antagonists, can be triggered in CA1 pyrami-
dal cells by the broad-spectrum potassium channel blocker
4-aminopyridine, by medium lacking Mg2+, by the GABA recep-
tor blockers penicillin and bicuculline, and by Ca2+-free medium
(Tian et al., 2005).
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ably glutamate, aspartate, or D-serine, via an action potential-in-
dependent process, can be released from astrocytes in sufficient
quantities to elicit NMDA receptor-mediated short-range syn-
chronous depolarizations of CA1 pyramidal neurons. The role
of SICs in epilepsy is uncertain, although the most intriguing fea-
ture of this astrocyte-driven phenomenon is the induction of
highly local, microsynchronous firing among populations of two
to four adjacent neurons. Thus, whereas SICs do not themselves
represent interictal bursts for reasons discussed above, they are
well poised to produce the ‘‘grandfather neuron,’’ which initiates
such bursts in epileptic tissue that is already prone to excitability.
Glial Glutamate Transporters in Epilepsy
Five subtypes of glutamate transporter have been cloned:
EAAT1 (known as GLAST in rodents), EAAT2 (GLT-1 in rodents),
EAAT3 (or EAAC-1), EAAT4, and EAAT5. Two glial-specific trans-
porters are expressed in astrocytes, EAAT1/GLAST and EAAT2/
GLT-1, which are largely responsible for glutamate clearance
from the extracellular space (Rothstein et al., 1994; Lehre
et al., 1995). The glial transporters appear to account for the
majority of glutamate uptake in the brain, as judged by studies
employing mice with genetic deletion (Tanaka et al., 1997) or
antisense oligonucleotide-mediated inhibition (Rothstein et al.,
1996) of GLT-1. Glutamate clearance by transporters undoubt-
edly plays a critical role in limiting extrasynaptic glutamate
receptor activation.
Several experiments in knockout mice suggest that impaired
glutamate uptake by astrocytes has the potential to contribute
to the development of seizures. Mice with genetic deletions of
the astroglial transporter GLT-1/EAAT2 develop spontaneous
seizures, which suggests that GLT-1 is critical for normal gluta-
matergic transmission in the CNS (Tanaka et al., 1997). Yet,
the same study showed that the knockdown of GLT-1 with anti-
sense oligonucleotides does not result in the development of
seizures. Additional experiments with conditional transporter
knockouts are needed to gain a better understanding of how
the regulation of extracellular glutamate contributes to seizures
and epilepsy.
Whether glutamate transporters are altered in human epilepsy
is controversial. Tessler et al. (1999) and Eid et al. (2004) found no
change in transporter expression in resected tissue from tempo-
ral lobe epilepsy patients. This stands in contrast to the work of
Mathern et al. (1999), who demonstrated regionally specific
changes in EAAT1-3 expression in the hippocampus in temporal
lobe epilepsy. Proper et al. (2002) examined transporter expres-
sion in sclerotic and nonsclerotic tissue and found that EAAT3,
a glutamate transporter with glial and neuronal distribution,
was increased in both groups. There are several possible expla-
nations for the different observations among researchers,
including differences in tissue processing between groups, in
disease severity, or epileptogenesis development. It is unknown
whether changes in transporters represent causative or com-
pensatory changes during epileptogenesis.
Functionally Linked Water and Potassium Homeostasis
Changes in ECS volume or extracellular potassium level power-
fully regulate the excitability of brain tissue. As with any closedsystem, when neuronal and/or glial cells of the CNS swell, extra-
cellular space inevitably shrinks. A reduction in ECS volume pro-
duces hyperexcitability and enhanced epileptiform activity (Du-
dek et al., 1990). Increasing ECS volume, on the other hand,
has the opposite effect, attenuating hyperexcitability in hippo-
campal slices exposed to high physiological levels of extracellu-
lar potassium or zero-calcium bathing medium (Traynelis and
Dingledine, 1989; Dudek et al., 1990). Moreover, electrolyte im-
balances are often associated with seizures. This is especially
true in hypo-osmolar situations such as hyponatremia (Saly
and Andrew, 1993) or overhydration, which causes a rapid
drop in extracellular osmolarity (Manley et al., 2004). We focus
attention here on the fact that glial volume largely regulates the
size of the ECS (Sykova, 2005) and thereby controls both the
concentration and diffusion rate of extracellular transmitters
and ions as well as the strength of ephaptic (electric field) com-
munication among neurons. Decreasing ECS volume magnifies
the effects of transient changes in extracellular ion and/or trans-
mitter concentrations. When the ECS volume shrinks, ephaptic
interactions among tightly packed neurons would increase due
to an increase in the ohmic resistance of the ECS. Release of
transmitters from astrocytes via volume-sensitive anion chan-
nels could also increase as these cells swell.
Aquaporin 4 and Kir4.1
The underlying mechanisms by which changes in ECS osmolar-
ity affect brain excitability were not obvious from initial studies.
Most cells, including glia, have effective regulatory mechanisms
to move ions and water between extracellular and cytoplasmic
compartments (Olson and Kimelberg, 1995; Holthoff and Witte,
1996). Recent attention has pointed to aquaporins and certain
potassium channels as key mediators of ECS volume. The aqua-
porins are a family of at least 11 integral membrane proteins in
mammals that mediate constitutive and regulated transport of
water across cellular membranes in many organs, including the
brain (Amiry-Moghaddam and Ottersen, 2003). In the brain, the
water channel aquaporin 4 (AQP4) is predominantly, if not exclu-
sively, expressed in glia (Nielsen et al., 1997). AQP4 protein in as-
trocytes faces the neuropil but is especially concentrated at peri-
vascular endfeet (Nielsen et al., 1997; Nagelhus et al., 2004)
(Figure 2, left). This localization pattern makes AQP4 well suited
tomediate the bidirectional flow of water between brain extracel-
lular space and blood and consequently to regulate the osmolar-
ity of the interstitial fluid surrounding neurons in the brain. In-
deed, mice lacking AQP4 have decreased levels of brain water
following water intoxication and focal cerebral ischemia (Manley
et al., 2000) and impaired clearance of water in models of vaso-
genic edema (Papadopoulos et al., 2004). These observations
demonstrate an important role for AQP4 in brain water transport
under pathological conditions. However, other than sensorineu-
ral deafness, AQP4 knockout mice have no obvious CNS abnor-
malities under normal conditions (Manley et al., 2004).
The inwardly rectifying K+ channel, Kir4.1, is abundantly ex-
pressed in cortical astrocytes, where it directly or indirectly helps
set a very negative resting potential (Kucheryavykh et al., 2007;
Djukic et al., 2007). In the brain, Kir4.1 protein and transcripts
are found in 50% of astrocytes (Higashi et al., 2001; Schroder
et al., 2002). Like AQP4, Kir4.1 is also polarized in brainNeuron 58, April 24, 2008 ª2008 Elsevier Inc. 171
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perivascular space (Higashi et al., 2001) and subpial surface
on one end and neuropil on the other (Figure 2, left). Several key
observations support the hypothesis that AQP4 and Kir4.1 work
together to regulate potassium and water levels in the ECS.
First, AQP4 and Kir4.1 coimmunoprecipitate and colocalize to
the same subcellular regions (Nagelhus et al., 2004). Second,
AQP4 null mice have slower K+ clearance but no difference in
peak extracellular potassium concentration following electrical
stimulation of the cortex (Binder et al., 2006). Correspondingly,
these animals also showed a significant increase in the duration
of stimulus-evoked seizures. These data support the hypothesis
that AQP4 and Kir4.1 cooperate in the clearance of K+ and water
after neural activity. Because Kir4.1 faces capillaries and [K+]o is
higher in blood than CSF, Kir4.1 might function to import K+ from
the blood into the brain’s astrocyte syncytium. In this view, the
density of AQP4 and Kir4.1 channels on perivascular endfeet
and the rate of potassium import into the brain from blood would
be primary determinants of the ECS. Furthermore, blood vessel
endothelial cells are not very permeable to potassium, which
helps protect the brain. Unlike vitreous fluid in the eye (Newman
et al., 1984), blood is probably not amajor sink for distributing ex-
cess potassium in the brain. Potassium clearance in hippocam-
pal CA1 is delayed in slices from AQP4-deficient mice (Amiry-
Moghaddam et al., 2003), which reinforces the idea that water
flux through glial endfeet is necessary for efficient potassium
Figure 2. Hypothesis for Role of Astrocytes in Water Balance
Dysfunction in Epilepsy
The left panel depicts a typical bipolar brain astrocyte with processes in the
neuropil (bottom) and endfeet near the perivascular space (top). The distribu-
tion of aquaporin 4 water channels (red) and Kir4.1 potassium channels (blue)
is shown. Following neuronal activity, the potassium taken up into astrocytes
via Kir4.1 is accompanied by water entry through AQP4 to maintain osmotic
balance. Excess water may be dumped into the perivascular space by
AQP4. In the epileptic state (right panel), there is a partial redistribution of
AQP4 away from perivascular endfeet to the neuropil. The predicted conse-
quences of this redistribution include enhanced entry of water into the neuropil
but impaired egress of water into perivascular space, leading to astrocytic
swelling and reduced interstitial space volume and thus enhanced ephaptic
interactions among neurons.172 Neuron 58, April 24, 2008 ª2008 Elsevier Inc.buffering. For these reasons, a primary function of Kir4.1 may
be to act in concert with AQP4 to regulate ECS volume.
Although it has been known for quite some time that neuronal
excitability is sensitive to both osmolarity and the size of the ex-
tracellular space, emerging insights into the molecular mecha-
nisms by which extracellular volume is controlled by astrocytes
give rise to an intriguing and novel hypothesis for the devel-
opment of hyperexcitability after status epilepticus or traumatic
brain injury (Figure 2). During normal periods of activity, much
of the potassium released into the ECS by spiking neurons is
taken up by astrocytes and neurons. The notion is that normally
potassium uptake is accompanied by water influx via AQP4 into
astrocytes in the perisynaptic space and then excess water is
dumped via AQP4 at perivascular endfeet. By this means, focal
glial swelling and thus ECS shrinkage during hyperactivity could
normally be minimized. During seizures, there is focal swelling in
the area of the seizure focus (Traynelis and Dingledine, 1989;
Hattori et al., 2003; Binder et al., 2006). In sclerotic human hippo-
campi, AQP4 is redistributed from perivascular to perisynaptic
space (Eid et al., 2005), with an overall increase in AQP4 expres-
sion (Lee et al., 2004). The effect of this redistribution would plau-
sibly be to both enhance water entry near synapses and slow
water egress distantly (Figure 2, right), leading to local astrocyte
swelling with accompanying restriction in neuropil ECS.
Gap Junctions
Gap junctions consist of aggregates of connexin proteins that
form functional channels between adjacent cells (Unger et al.,
1999). Astrocytic processes are coupled through gap junctions
to form large intercellular networks, which allows astrocytes to
disperse small molecules such as K+ or glutamate and therefore
prevent their extracellular accumulation during neuronal firing.
However, a recent study weighs against the old notion that K+
buffering is primarily mediated by redistribution of K+ through
gap junctions in the glial syncytium (Wallraff et al., 2006). Con-
nexins 30 and 43 are required structural proteins of astrocyte
gap junctions (Nagy et al., 2004). Comparison of wild-type
mice with connexin-43 and connexin-30 double knockouts
shows that under most conditions the absence of gap junctions
had little effect on the spatial decay of K+ in the CA1 stratum ra-
diatum following antidromic spikes; only maximal stimulation led
to increased extracellular K+ levels in knockout compared to
wild-type mice. These results strongly suggest that gap junc-
tions in the glia syncytium play a negligible role in the spatial
redistribution of potassium. However, hippocampal slices from
mice lacking gap-junction-coupled astrocytes exhibited sponta-
neous interictal bursts in area CA1 (Wallraff et al., 2006), which
suggests that the loss of gap-junction-connected astrocytes
does indeed result in neuronal hyperexcitability. Whether hyper-
excitability is due to the inability to redistribute K+ through gap
junctions remains to be seen. It is not knownwhether other prop-
erties of glial cells are changed by knockout of the gap junction
proteins and what effects this might have on neuronal-astrocyte
signaling and neurotransmission.
Do Reactive Astrocytes Oppose or Exacerbate
Seizure Activity?
Almost all insults to the brain, including prolonged seizures,
result in reactive gliosis, which is characterized by severe
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cytes (Binder and Steinha¨user, 2006; Ravizza et al., 2008) as
well as the generation of new astrocytes from stem cells (Borges
et al., 2006). There are no reports of the global impact of selec-
tively preventing reactive gliosis in epilepsy, but studies of ische-
mic or traumatic brain injury could be relevant. For example,
Myer et al. (2006) used a conditional transgenic mouse in which
reactive, proliferating astrocytes were ablated by gangciclovir;
they measured neurodegeneration after moderate or severe
controlled cortical impact as a model of traumatic brain injury
(TBI). The ablation of reactive astrocytes carried out over the
week following moderate TBI markedly exacerbated neural
damage and increased leukocyte infiltration into the affected
cortical area. The consequence of gradually ablating proliferat-
ing astrocytes was similar after mild stab injury to the spinal
cord (Faulkner et al., 2004) or cortex (Bush et al., 1999). These
studies demonstrate a protective function of reactive astrocytes
during the week after mild injury, but do not address the acute
effects shortly after injury or the responsible mechanisms.
The entirety of changes that occur in astrocytes during epi-
lepsy, as well as the cellular and molecular processes responsi-
ble for astrogliosis, are still poorly understood. Astrocytes in the
region of brain inflammation undergo hypertrophy of cellular pro-
cesses, especially near the soma, which accentuates their stel-
late morphology and is associated with upregulation of the inter-
mediate filament proteins vimentin, nestin, and glial fibrillary
acidic protein. Many other proteins are upregulated in reactive
astrocytes, including mGluR3, mGluR5, mGluR8 (Aronica et al.,
2000; Tang et al., 2001; Tang and Lee, 2001; Notenboom
et al., 2006), the proinflammatory proteins COX2 and CXCR4
(Lee et al., 2007), nerve growth factor and its receptors (Sofro-
niew et al., 2001), estrogen receptor a (Tokuhara et al., 2005),
a variety of cytokines, including transforming growth factor b,
tumor necrosis factor a, interleukins 1, 4, 6, and 10, and enzymes
including iNOS and cathepsins D and G (Ridet et al., 1997; Lede-
boer et al., 2000; Hulshof et al., 2002). Glutamine synthase is
prominently downregulated in reactive astrocytes (Eid et al.,
2004). Do the functional changes in reactive astrocytes expected
from these expression changes modify seizure susceptibility?
Pro- and Anticonvulsant Roles of Cytokines
Released by Reactive Astrocytes
Astrocytes have dynamic functions and can produce many pro-
and anti-inflammatory molecules. The production of TNFa and
IL-1b by astrocytes can lead to beneficial or detrimental out-
comes depending on which receptors are activated and the
timing of expression (Wilde et al., 2000; Bernardino et al.,
2005; Vezzani and Granata, 2005). Work by Vezzani et al. (2000)
demonstrated that transgenic overexpression in astrocytes of IL-
1Ra, a natural antagonist of IL-1b, significantly delays the onset
and reduces the duration of generalized seizures in mice chal-
lenged with bicuculline; these effects of IL-1Ra were absent in
the IL-1R1 knockout mouse, implying that activation of IL-1R1
by IL-1b can reduce seizure threshold. Seizures rapidly induce
production of both IL-1b and IL-1Ra in astrocytes (De Simoni
et al., 2000). These findings together point to an important role
of astrocytic IL-1b in regulating seizure susceptibility. Like-
wise, the cytokines IL-10, IL-4, and transforming growth factor
b, which are all produced by astrocytes after various insults(Ledeboer et al., 2000; Rasley et al., 2006), reduce expression
of the proinflammatory cytokines IL-1b, IL-6, and tumor necrosis
factor a (TNFa), as well as nitric oxide (Ledeboer et al., 2000).
TNFa, a pleiotropic cytokine produced by both astrocytes and
activated microglia, is implicated in diverse biological events
from inflammation to proliferation depending on the cell target,
exposure duration, and receptor activated. TNFa appears to
cause cell damage through activation of TNFR1, which contains
an intracellular ‘‘death domain.’’ Activation of TNFR2, on the
other hand, reduces the intensity of acute kainate-evoked sei-
zures (Balosso et al., 2005), suggesting that the balance between
activation of TNFR1 and TNFR2 will determine whether the net
effect of TNFa release is pro- or anticonvulsant. TNFa also
appears to promote neuronal excitability, as described next.
Potentiation of Astrocytic Glutamate Signaling
in Reactive Astrocytes
There is no question that astrocytes can release glutamate and
that under certain pathological conditions (e.g., Fiacco et al.,
2007) this phenomenon is more noticeable. Curiously, 20–40 s
of continuous astrocyte stimulation appears to be necessary to
increase spontaneous mEPSC frequency in granule cells, even
though the astrocytic Ca2+ signal peaks in 10 s or less (Jourdain
et al., 2007). A similarly long latency between astrocyte Ca2+ sig-
nals and CA1 pyramidal cell SICs has typically been reported
(Angulo et al., 2004; Fellin et al., 2004; Tian et al., 2005), suggest-
ing that a series of steps after Ca2+ elevation may intervene be-
fore productive glutamate release. What could these intervening
steps be? Clues can be drawn from studies of glutamate release
from cultured astrocytes.
Studies by Bezzi and colleagues (Bezzi et al., 1998, 2001)
identified TNFa as a prominent glutamate release modulator in
cultured astrocytes. TNFa released into the medium by reactive
astrocytes and activated microglia activates astrocytic TNFR1
receptors, which leads to production of a prostaglandin; the
formed prostaglandin in turn strongly increases glutamate re-
lease from astrocytes in response to activation of Gq-coupled
GPCRs in astrocytes. A similar situation obtains for synergy be-
tween TNFR1 activation and activation by released ATP of Gq-
coupled P2Y1 receptors on astrocytes (Domercq et al., 2006).
In this study, it was further shown that glutamate release evoked
by P2Y1 receptor activation was largely suppressed in astro-
cytes isolated from TNFR1 null mice or in astrocytes treated
with cyclooxygenase inhibitors or the Ca2+ chelator BAPTA-
AM. TNFa release was preserved in each of the above conditions
but could, however, be reduced by inhibitors of ERK-type MAP
kinase, suggesting that this MAP kinase pathway is upstream
of TNFa release. These findings together cement the roles of
TNFa and a prostanoid (possibly PGE2 or PGD2) as key boosters
of astrocytic glutamate release. The induction ofmGluR5 in reac-
tive astrocytes could synergize with this amplification system.
The overall picture is that reactive astrocytes or activated micro-
glia, via release of TNFa and subsequently PGE2, amplify astro-
cytic glutamate release in response to astrocytic Gq-coupled
GPCR activation. This ‘‘two-hit’’ hypothesis (Figure 3) for priming
of astrocytic glutamate release by activated microglia and reac-
tive astrocytes presents a sinister feature of sclerotic brain tissue
that could, by enhancing SIC frequency, depolarize neurons in
the affected regions and thus promote seizure initiation.Neuron 58, April 24, 2008 ª2008 Elsevier Inc. 173
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Brain Could Promote Seizures
Sclerotic brain tissue removed during epilepsy surgery is charac-
terized by downregulation of glutamine synthetase in astrocytes
(Eid et al., 2004). In the brain, glutamine synthetase is expressed
nearly exclusively by astrocytes and oligodendroglia (Martinez-
Hernandez et al., 1977). Following its synaptic release from the
terminals of glutamatergic neurons, glutamate is transported
into astrocytes where it is converted by glutamine synthetase
into glutamine; glutamine in turn is exported and taken up by
neurons, where it is converted back to glutamate by mitochon-
drial glutaminase. This glutamine cycle normally serves as a ma-
jor mechanism for ammonia detoxification in the brain and also
as a buffered reservoir of a precursor (glutamine) for glutamate
and GABA synthesis (Hassel and Dingledine, 2006). Systemic
administration of a glutamine synthetase inhibitor causes severe
seizures in laboratory animals (Folbergrova et al., 1969; Szeg-
edy, 1978), which supports the idea that impaired glutamate to
glutamine cycling could contribute to seizures in the epileptic
brain. Indeed, glutamine-glutamate cycling appears to be
slowed in sclerotic human hippocampus removed during epi-
lepsy surgery (Petroff et al., 2002).
There are several potential mechanisms by which reduced
glutamine synthetase could promote seizures. First, downregu-
lation of glutamine synthetase could result in the accumulation
of glutamate in astrocytes and thus its buildup in the extracellular
space, because rapid metabolism of intracellular glutamate ap-
pears to be needed for glutamate uptake into astrocytes (Otis
and Jahr, 1998). Second, because vesicular GABA levels are in
equilibrium with intraterminal glutamate concentration, which in
turn is partially dependent upon glutamine transport into inhibi-
tory neurons, downregulation of glutamine synthetase could par-
tially deplete inhibitory synaptic terminals of GABA and thus im-
pair GABAergic inhibition. Evidence for this notion was recently
Figure 3. Hypothesis for Enhanced Ability of Reactive Astrocytes to
Release Glutamate
(Left) Scheme for control of astrocytic glutamate release by twoG protein-cou-
pled receptors. (Right) In the epileptic brain, mGluR5 is upregulated, and acti-
vated microglia as well as reactive astrocytes release TNFa, which acts on
TNFR1 receptors in a pathway that promotes prostaglandin formation. Prosta-
glandin in turn activates a Gq-coupled prostanoid receptor that boosts intra-
astrocyte Ca2+ release and thus astrocytic glutamate release. Hypothesis
adapted from work reported by Bezzi et al. (1998, 2001) and Domercq et al.
(2006).174 Neuron 58, April 24, 2008 ª2008 Elsevier Inc.provided by Liang et al. (2006), who showed that inhibition of glu-
tamine synthesis by methionine sulfoximine reduced the ampli-
tude of IPSCs in CA1 pyramidal neurons during repetitive stimu-
lus trains, an effect that was traced to reduced quantal content
rather than lower release probability. Importantly, the effect of
the inhibitor could be overcome by replacing the lost glutamine
with bath perfusion. A similar effect of methionine sulfoximine
was not seen on evoked EPSCs (Kam andNicoll, 2007), although
in this study the synapses were not subjected to stimulus trains.
Moving forward, it will be important to determine whether synap-
tic inhibition is reduced in the vicinity of reactive astrocytes and
whether reversal of this effect occurs when GS is selectively
reintroduced into reactive astrocytes.
Impaired Water and Potassium Balance
in Reactive Astrocytes
Comparison of hippocampal slices obtained from patients with
or without mesial temporal sclerosis shows that K+ buffering is
impaired in sclerotic tissue (Heinemann et al., 2000). In the pilo-
carpine epilepsy model, the ability of Ba2+ (a blocker of all known
Kir) to increase baseline [K+]o was dramatically lower (Gabriel
et al., 1998), which suggests that Kir currents in astrocytes are
reduced several days after status epilepticus. This fits well with
a patch-clamp study that provided direct evidence for smaller
Kir currents in astrocytes from epileptic hippocampus (Schroder
et al., 1999; Hinterkeuser et al., 2000). Together, these data as-
sociate impaired K+ buffering with reduced expression of func-
tional Kir in the sclerotic condition but do not demonstrate that
Kir themselves are the major K+ clearance route. Impaired astro-
cytic K+ buffering would be expected to result in slower K+ clear-
ance, which in turn could lower seizure threshold and thereby
contribute to seizure generation. The prediction is that in epilep-
tic tissue redistribution of glial AQP4 away from perivascular
membranes perturbs water flux and thus impairs K+ buffering.
Under these conditions, a normally unremarkable level of neuro-
nal activity could exacerbate glial swelling and thus ECS shrink-
age, which would increase the likelihood of seizures. Whereas
the data are consistent with the idea that AQP4 and Kir4.1 partic-
ipate in clearance of K+, additional studies are required to clarify
the expression and regulation of both AQP4 and Kir4.1 in the hip-
pocampus and their changes during epileptogenesis. In sum, an
impaired ability of reactive glia to redistribute water and thereby
maintain osmotic balance throughout brain microdomains could
contribute to the hyperexcitable epileptic state.
Summary and Open Issues
Astrocytes in the healthy brain mediate glutamate reuptake, reg-
ulate the ionic environment and interstitial volume, and serve as
a component of the neurovascular unit that controls blood-brain
barrier permeability (Abbott et al., 2006). Although reactive astro-
cytes in the epileptic focus are well known to undergo extensive
morphological and physiological changes that modify these
three overarching functions, the implications for epilepsy are
just emerging. Moreover, we have only a primitive understanding
of astrocyte heterogeneity and its consequences.
In models of ischemic or traumatic brain injury, conditional ab-
lation of proliferating astrocytes increases neuronal injury and in-
creases infiltration of the damaged region by leukocytes, which
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in these two conditions. However, not all reactive astrocytes
have undergone recent cell division. Additionally, environmental
cues for astrocytes in the epileptic brain could well differ from
those in the ischemic brain, so generalizing results from ischemia
to epilepsy may not be prudent. At least two lines of evidence
suggest that reactive astrocytesmight contribute to the hyperex-
citable condition. First, the redistribution of AQP4 in the epileptic
state, away from perivascular membranes toward neuropil,
should create a situation allowing rapid astrocytic swelling in
neuropil with consequent shrinkage in ECS and enhanced
ephaptic interactions among tightly packed neurons (Figure 2).
Second, neuroinflammatory signaling pathways engaged in re-
active glia in epileptic foci may allow astrocytic glutamate signal-
ing to become prominent enough to contribute to the hyperexcit-
able state (Figure 3). Although reactive astrocytes develop both
pro- and antiepileptic properties, the preponderance of current
evidence favors the former. Going forward, it would be valuable
to determine whether ablation of proliferating astrocytes in
status epilepticus models of epilepsy exacerbates or blunts neu-
rodegeneration, changes in synaptic plasticity, leucocyte infiltra-
tion, cognitive impairment, and other features of the latent period
that precede the appearance of spontaneous seizures.
Over the past few years, the consequences of Ca2+ signaling in
astrocytes have received considerable attention. Astrocytes,
particularly in pathological situations involving neuroinflamma-
tion, may be important active members of many synapses, their
roles extending well beyond structural support or extracellular
ion scavengers. The existence of astrocytic glutamate release,
most convincingly demonstrated in tissue culture, is challenging
the old view of astrocytes as simple support structures. In a con-
text-dependent manner, release of glutamate from a single as-
trocyte can depolarize two to four adjacent neurons; suchmicro-
synchrony undoubtedly elevates excitability of the involved
circuits. Determining whether interictal bursts can be triggered
in the epileptic brain by microsynchronous depolarizations will
require devising ways to isolate the consequences of astrocytic
glutamate release with normal synaptic transmission intact.
The act of preparing hippocampal brain slices necessarily in-
jures the tissue and might therefore cause a variable degree of
reactive astrogliosis. Given the clear demonstration that TNFa,
which is prominently secreted from reactive astrocytes and acti-
vated microglia, can increase astrocytic glutamate release sub-
stantially (Bezzi et al., 2001; Domercq et al., 2006), the possibility
that astrogliosis is essential for SICs and other manifestations of
gliotransmission must be considered. This possibility can be
explored simply by determining whether inhibitors of cyclooxy-
genase or TNFR1 prevent these phenomena in brain slices.
Insights gleaned from careful studies of the properties of reac-
tive astrocytes suggest several novel targets for drug develop-
ment, including allosteric potentiators of glutamine synthetase,
regulators of AQP4 trafficking, interleukin 1 antagonists, and
agonists or allosteric potentiators of TNFR2. Unraveling the
specific pathologic and protective pathways in reactive astro-
cytes has begun, and much work remains, but today it is clear
that astrocytes play prominent roles in information proces-
sing in the epileptic brain. These are, indeed, not your father’s
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